Cochrane2020Ia
Cochrane Review: Non-pharmacological care for opioid withdrawal in newborns
Zusammenfassung
# Non-pharmacological care for opioid withdrawal in newborns.
## BACKGROUND
The prevalence of substance use, both prescribed and non-prescribed, is increasing in many areas of the world. Substance use by women of childbearing age contributes to increasing rates of neonatal abstinence syndrome (NAS). Neonatal opioid withdrawal syndrome (NOWS) is a newer term describing the subset of NAS related to opioid exposure. Non-pharmacological care is the first-line treatment for substance withdrawal in
Kerninformationen
dance for clinical practice.
## OBJECTIVES
To evaluate the safety and efficacy of non-pharmacological treatment of infants at risk for, or having symptoms consistent with, opioid withdrawal on the length of hospitalization and use of pharmacological treatment for symptom management. Comparison 1: ...
used the standard search strategy of Cochrane Neonatal to search CENTRAL (2019, Issue 10); Ovid MEDLINE; and CINAHL on 11 October 2019. We also searched clinical trials databases and the reference lists of retrieved articles for randomized controlled trials (RCTs), quasi-RCTs, and cluster trials.
...
the mother-infant dyad. We presented non-randomized studies identified in the search process narratively.
## DATA COLLECTION AND ANALYSIS
We used standard methodological procedures expected by Cochrane. We used the GRADE approach to assess the certainty of evidence. Primary outcomes in infants at ...
Fragen zu diesem Thema?
ClariMed durchsucht alle Leitlinien mit KI und liefert quellenbasierte Antworten in Sekunden.
Jetzt auf ClariMed suchenVerwandte Leitlinien
Cochrane2021
Cochrane Review: Sedatives for opioid withdrawal in newborn infants
Cochrane2021
Cochrane Review: Opioid treatment for opioid withdrawal in newborn infants
Cochrane2025
Cochrane Review: Acupuncture for neonatal abstinence syndrome in newborn infants
Cochrane2023
Cochrane Review: Opioids for procedural pain in neonates
Cochrane2023